Variant report
Variant | nsv982154 |
---|---|
Chromosome Location | chr9:2333712-2335313 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:3)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:3 , 50 per page) page:
1
No data |
No data |
No data |
Variant related genes | Relation type |
---|---|
ENSG00000236404 | chromatin interactions |
ENSG00000147852 | chromatin interactions |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs549795677 | chr9:2333761-2333762 | Weak transcription | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
2 | rs140677149 | chr9:2333770-2333771 | Weak transcription | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
3 | rs540114984 | chr9:2333780-2333781 | Weak transcription | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
4 | rs188706241 | chr9:2333803-2333804 | Weak transcription | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
5 | rs561825635 | chr9:2333873-2333874 | Weak transcription | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
6 | rs566348297 | chr9:2333916-2333917 | Weak transcription | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
7 | rs191802126 | chr9:2333921-2333922 | Weak transcription | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
8 | rs554822865 | chr9:2333944-2333945 | Weak transcription | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
9 | rs183557094 | chr9:2333945-2333946 | Weak transcription | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
10 | rs914497 | chr9:2333979-2333980 | Weak transcription | Chromatin interactive region | 2 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
11 | rs12338751 | chr9:2333996-2333997 | Weak transcription | Chromatin interactive region | 2 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
12 | rs186762359 | chr9:2334003-2334004 | Weak transcription | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
13 | rs576808145 | chr9:2334031-2334032 | Weak transcription | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
14 | rs149767374 | chr9:2334035-2334036 | Weak transcription | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
15 | rs564841526 | chr9:2334057-2334058 | Weak transcription | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
16 | rs564673751 | chr9:2334108-2334109 | Weak transcription | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
17 | rs145723209 | chr9:2334144-2334145 | Weak transcription | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
18 | rs541262902 | chr9:2334155-2334156 | Weak transcription | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
19 | rs76656315 | chr9:2334163-2334164 | Weak transcription | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
20 | rs537464265 | chr9:2334167-2334168 | Weak transcription | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
21 | rs560923681 | chr9:2334198-2334199 | Weak transcription | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
22 | rs529825410 | chr9:2334211-2334212 | Weak transcription | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
23 | rs560095924 | chr9:2334230-2334231 | Weak transcription | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
24 | rs549886200 | chr9:2334265-2334266 | Weak transcription | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
25 | rs34305402 | chr9:2334269-2334270 | Weak transcription | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
26 | rs74506894 | chr9:2334305-2334306 | Weak transcription | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
27 | rs552156183 | chr9:2334319-2334320 | Weak transcription | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
28 | rs540302538 | chr9:2334323-2334324 | Weak transcription | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
29 | rs368289401 | chr9:2334332-2334333 | Weak transcription | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
30 | rs116900844 | chr9:2334347-2334348 | Weak transcription | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
31 | rs12344016 | chr9:2334358-2334359 | Weak transcription | Chromatin interactive region | 2 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
32 | rs528927469 | chr9:2334392-2334393 | Weak transcription | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
33 | rs548809698 | chr9:2334428-2334429 | Weak transcription Enhancers | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
34 | rs568536516 | chr9:2334483-2334484 | Weak transcription Enhancers | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
35 | rs2017987 | chr9:2334516-2334517 | Weak transcription Enhancers | Chromatin interactive region | 2 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
36 | rs10965727 | chr9:2334521-2334522 | Weak transcription Enhancers | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
37 | rs369491872 | chr9:2334543-2334544 | Weak transcription Enhancers | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
38 | rs2018186 | chr9:2334581-2334582 | Weak transcription Enhancers | Chromatin interactive region | 2 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
39 | rs539458747 | chr9:2334613-2334614 | Weak transcription Enhancers | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
40 | rs570314460 | chr9:2334678-2334679 | Weak transcription Enhancers | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
41 | rs548988772 | chr9:2334720-2334721 | Weak transcription Enhancers | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
42 | rs184078569 | chr9:2334744-2334745 | Weak transcription Enhancers | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
43 | rs540948003 | chr9:2334747-2334748 | Weak transcription Enhancers | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
44 | rs1109816 | chr9:2334748-2334749 | Weak transcription Enhancers | Chromatin interactive region | 2 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
45 | rs576215240 | chr9:2334769-2334770 | Weak transcription Enhancers | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
46 | rs142225975 | chr9:2334780-2334781 | Weak transcription Enhancers | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
47 | rs535256708 | chr9:2334783-2334784 | Weak transcription Enhancers | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
48 | rs543613636 | chr9:2334812-2334813 | Weak transcription Enhancers | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
49 | rs151183434 | chr9:2334834-2334835 | Weak transcription Enhancers | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
50 | rs35023105 | chr9:2334842-2334843 | Weak transcription Enhancers | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Gastric cancer | 16715143 | CNVD |
Glioblastoma multiforme | 22286061 | CNVD |
Esophageal squamous carcinoma | 18405350 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Intracranial aneurysm | 16715129 | CNVD |
Primary mediastinal b-cell lymphoma | 17728785 | CNVD |
Disorders of sex development | 22290220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Sudden cardiac death | 19188705 | CNVD |
Non-small cell lung cancer | 21829676 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Cancer | 21183584 | CNVD |
Non-small cell lung cancer | 21952639 | CNVD |
Disorders of sex development | 21048976 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Intellectual disability | 22102821 | CNVD |
abnormal development | 18461090 | CNVD |
Honadal dysgenesis | 21048976 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Lung cancer | 16740712 | CNVD |
Malignant peripheral nerve sheath tumor | 18522746 | CNVD |
Basal cell lymphoma | 17170743 | CNVD |
Follicular lymphoma | 17170743 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Breast cancer | 16608533 | CNVD |
Hodgkin''s lymphoma | 18641027 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Breast cancer | 16272173 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Breast cancer | 17133270 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Cervical cancer | 21063398 | CNVD |
Retinoblastoma | 22278416 | CNVD |
Splenic marginal zone lymphoma | 18492102 | CNVD |
Melanoma | 18172304 | CNVD |
Biliary cancer | 19435499 | CNVD |
Gastric cancer | 21586687 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Myopathy | 18421352 | CNVD |
Neuroblastoma | 18664255 | CNVD |
Acute lymphoblastic leukemia | 18957548 | CNVD |
Myeloproliferative neoplasm | 17564968 | CNVD |
Malignant meningioma | 17937814 | CNVD |
Glioma | 21971842 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 17603634 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Oligodendroglial tumors | 17285580 | CNVD |
Cutaneous squamous cell carcinomas | 19131950 | CNVD |
Small bowel adenocarcinoma | 21586687 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Chordoma | 18071362 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Chordoma | 21602918 | CNVD |
Renal cell carcinoma | 18592004 | CNVD |
Developmental delay | 19490664 | CNVD |
Pleomorphic xanthoastrocytoma | 20730472 | CNVD |
microdeletion syndrome | 16199537 | CNVD |
Non-syndromic sensorineural hearing loss | 21987784 | CNVD |
Cancer | 20164919 | CNVD |
Chronic myeloid leukemia | 21384125 | CNVD |
Ovarian cancer | 21720365 | CNVD |
Non-syndromic sensorineural hearing loss | 21030649 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Developmental delay | 21147756 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Lung cancer | 18438408 | CNVD |
Autism | 20531469 | CNVD |
XY gonadal dysgenesis | 20685758 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Oral cancer | 21386901 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Acute lymphoblastic leukemia | 21339820 | CNVD |
Myelodysplastic syndrome | 21251322 | CNVD |
Breast cancer | 21785460 | CNVD |
Prostate cancer | 18632612 | CNVD |
Esophageal adenocarcinoma | 19417022 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Breast cancer | 21364760 | CNVD |
Breast cancer | 21858162 | CNVD |
Renal cell carcinoma | 21668985 | CNVD |
Autism | 22495311 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Gastrointestinal stromal cancer | 20877625 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Developmental delay | 21373258 | CNVD |
T-cell acute lymphoblastic leukemia | 18185524 | CNVD |
Malignant fibrous histiocytomas | 21085701 | CNVD |
Hepatocellular carcinoma | 18803288 | CNVD |
Schizophrenia | 23813976 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr9:2333000-2334400 | Weak transcription | Fetal Muscle Trunk | muscle |
2 | chr9:2333000-2335200 | Weak transcription | H9 Cell Line | embryonic stem cell |
3 | chr9:2334400-2335400 | Enhancers | Fetal Muscle Trunk | muscle |
4 | chr9:2334800-2335600 | Enhancers | Ovary | ovary |
5 | chr9:2334800-2335600 | Enhancers | Right Atrium | heart |
6 | chr9:2334800-2339000 | Enhancers | Adipose Nuclei | Adipose |
7 | chr9:2335000-2335400 | Enhancers | Skeletal Muscle Female | skeletal muscle |
8 | chr9:2335000-2335400 | Enhancers | Spleen | Spleen |
9 | chr9:2335000-2335600 | Enhancers | Fetal Muscle Leg | muscle |
10 | chr9:2335000-2335600 | Enhancers | Left Ventricle | heart |
11 | chr9:2335000-2335600 | Enhancers | Right Ventricle | heart |
12 | chr9:2335200-2335400 | Enhancers | H9 Cell Line | embryonic stem cell |
13 | chr9:2335200-2335400 | Enhancers | Mesenchymal Stem Cell Derived Adipocyte Cultured Cells | ES cell derived |
14 | chr9:2335200-2335600 | Enhancers | Psoas Muscle | Psoas |
15 | chr9:2335200-2336000 | Enhancers | Adipose Derived Mesenchymal Stem Cell Cultured Cells | ES cell derived |